Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1061]
News [1546]
Articles [90]
Editorials [10]
Conferences [133]
elearning [2]
Participation of Africa to global randomised controlled clinical trials
Dr Fidel Rubagumya - Rwanda Military Hospital, Kigali, Rwanda
Participation of Africa to global randomised controlled clinical trials ( Dr Fidel Rubagumya - Rwanda Military Hospital, Kigali, Rwanda )
8 Mar 2023
Choosing Wisely campaigns in Africa
Dr Fidel Rubagumya - Rwanda Military Hospital, Kigali, Rwanda
Choosing Wisely campaigns in Africa ( Dr Fidel Rubagumya - Rwanda Military Hospital, Kigali, Rwanda )
8 Mar 2023
Pembrolizumab plus docetaxel used to treat patients with metastatic castration...
Prof Daniel Petrylak - Yale University Cancer Center, New Haven, USA
Pembrolizumab plus docetaxel used to treat patients with metastatic castration-resistant prostate cancer ( Prof Daniel Petrylak - Yale University Cancer Center, New Haven, USA )
6 Mar 2023
SG monotherapy demonstrates a high response rate in PT-ineligible patients with...
Prof Daniel Petrylak - Yale University Cancer Center, New Haven, USA
SG monotherapy demonstrates a high response rate in PT-ineligible patients with mUC who progressed after CPI therapy ( Prof Daniel Petrylak - Yale University Cancer Center, New Haven, USA )
6 Mar 2023
Raising awareness of the burden of cervical cancer in the Eastern Mediterranean...
Dr Ibtihal Fadhil - Eastern mediterranean NCD Alliance, Kuwait City, Kuwait
Raising awareness of the burden of cervical cancer in the Eastern Mediterranean region ( Dr Ibtihal Fadhil - Eastern mediterranean NCD Alliance, Kuwait City, Kuwait )
2 Mar 2023
Cancer Communications
Dr Soumitra Datta - Tata Medical Center, Kolkata, India
Cancer Communications ( Dr Soumitra Datta - Tata Medical Center, Kolkata, India )
2 Mar 2023
Does the mind matter in Cancer?
Dr Soumitra Datta - Tata Medical Center, Kolkata, India
Does the mind matter in Cancer? ( Dr Soumitra Datta - Tata Medical Center, Kolkata, India )
2 Mar 2023
Improving access to palliative care by enhancing primary care services in an...
Dr Malar Velli Segarmurthy - Ministry of Health Malaysia, Putrajaya, Malaysia
Improving access to palliative care by enhancing primary care services in an upper middle-income country ( Dr Malar Velli Segarmurthy - Ministry of Health Malaysia, Putrajaya, Malaysia )
28 Feb 2023
Bladder sparing: Risk-enabled therapy after initiating neoadjuvant chemo allows...
Dr Daniel Geynisman - Fox Chase Cancer Center, Pennsylvania, USA
Bladder sparing: Risk-enabled therapy after initiating neoadjuvant chemo allows active surveillance of some MIBC ( Dr Daniel Geynisman - Fox Chase Cancer Center, Pennsylvania, USA )
24 Feb 2023
Pembrolizumab shows notable antitumour activity for patients with high-risk...
Prof Andrea Necchi - The Vita-Salute San Raffaele University, Milan, Italy
Pembrolizumab shows notable antitumour activity for patients with high-risk non–muscle-invasive bladder cancer ( Prof Andrea Necchi - The Vita-Salute San Raffaele University, Milan, Italy )
23 Feb 2023
Nivolumab and salvage nivolumab plus ipilimumab for aRCC
Prof Michael Atkins - Georgetown Lombardi Comprehensive Cancer Center...
Nivolumab and salvage nivolumab plus ipilimumab for aRCC ( Prof Michael Atkins - Georgetown Lombardi Comprehensive Cancer Center, Georgetown, USA )
18 Feb 2023
Anti-PSMA antibody radiolabeled with 177Lu improves MFS in high-risk nmCRPC
Prof Scott Tagawa - Weill Cornell Medicine, New York City, USA
Anti-PSMA antibody radiolabeled with 177Lu improves MFS in high-risk nmCRPC ( Prof Scott Tagawa - Weill Cornell Medicine, New York City, USA )
18 Feb 2023

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation